Immuron (IMRN) Total Current Liabilities (2016 - 2025)
Immuron (IMRN) posted quarterly Total Current Liabilities of $19662.1 for Q3 2025, down 27.15% year-over-year from $26989.8 in Q3 2024, and down 98.44% quarter-over-quarter from $1.3 million in Q2 2025.
Immuron (IMRN) Total Current Liabilities (2016 - 2025) Analysis & Trends
Immuron's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $19662.1 for Q3 2025.
- In Q3 2025, Total Current Liabilities fell 27.15% year-over-year to $19662.1; the TTM figure through Sep 2025 stood at $19662.1 (down 27.15% YoY), while the FY2025 annual figure was $19662.1, down 27.15% from the prior year.
- Total Current Liabilities for Q3 2025 stood at $19662.1, down from $1.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $1.8 million in Q2 2024, with the low at $14477.7 in Q4 2023.
- The 5-year median for Total Current Liabilities is $1.0 million (2022), against an average of $855990.8.
- The sharpest annual moves came in 2021 and 2023: Total Current Liabilities jumped 16645.17% in 2021, then slumped 98.53% in 2023.
- Immuron's Total Current Liabilities stood at $821216.7 in 2021, then increased by 20.25% to $987488.0 in 2022, then plunged by 98.53% to $14477.7 in 2023, then jumped by 7708.68% to $1.1 million in 2024, then plunged by 98.26% to $19662.1 in 2025.
- Business Quant data shows IMRN's Total Current Liabilities at $19662.1 in Q3 2025, $1.3 million in Q2 2025, and $1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | 19,662.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 19,662.09 |
| Jun 30, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 9, 2024 | 26,989.79 |
| Jun 30, 2024 | 1.78 Mn |
| Dec 31, 2023 | 14,477.66 |
| Sep 28, 2023 | 1.45 Mn |
| Aug 30, 2023 | 22,191.39 |
| Jun 30, 2023 | 1.48 Mn |
| Dec 31, 2022 | 987,488.00 |
| Aug 31, 2022 | 1.05 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Dec 31, 2021 | 821,216.68 |
| Jun 30, 2021 | 863,888.67 |
| Dec 31, 2020 | 4,904.20 |
| Sep 1, 2020 | 516,411.00 |
| Jun 30, 2020 | 338,466.42 |
| Dec 31, 2019 | 5,164.11 |
| Jun 30, 2019 | 837,436.32 |
| Dec 31, 2018 | 803,338.00 |